Sangamo BioSciences | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Alaunos Therapeutics USD 2K 0 2024-12
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Bayer EUR 2.52B 0 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Cipla INR 1.62B 100K 2025-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 248K 0 2024-12
CSL USD 576M 19M 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Grifols EUR 119.6M 0 2024-12
Ionis Pharmaceuticals USD 159K 1000 2025-03
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Tectonic Therapeutic USD 2K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Sangamo BioSciences Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.